EUVIMEDEUVIMED entdecken
Crossref

Cell-free DNA methylation-based inflammation score as a marker for hepatocellular carcinoma among people living with HIV

Kyeezu Kim, Yinan Zheng, Brian T Joyce, Drew R Nannini, Jun Wang, Yishu Qu, Claudia A Hawkins, Edith Okeke, Olufunmilayo A Lesi, Lewis R Roberts, Demirkan B Gursel, Fatimah B Abdulkareem und 17 weitere

Hepatology International · 2025-06 · 19 (3) · 596-606

DOI: 10.1007/s12072-024-10768-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hepatology International, online erschienen am 20.12.2024. Verfasst von Kyeezu Kim und 28 weiteren Autor:innen. Beteiligte Einrichtung: Sungkyunkwan University School of Medicine, 2066 Seobu-ro, Jangan-gu, Suwon-si, Gyeonggi-do, 16419, South Korea. kyeezu.kim@skku.edu. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, DNA Methylation, HIV Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: NCI NIH HHS, National Research Foundation of Korea, Division of Cancer Prevention, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: People living with the human immunodeficiency virus (HIV) are at a greater risk of developing hepatocellular carcinoma (HCC), potentially due to the stimulation of inflammation by HIV infection. Inflammation-related DNA methylation signatures obtained in liquid biopsy, such as circulating cell-free DNA (cfDNA), may serve as promising minimally invasive biomarkers that can inform diagnosis of HCC. METHODS: Using data from 249 individuals with HIV (114 individuals with normal liver conditions, 69 with fibrosis, 30 with cirrhosis, and 36 with HCC), we constructed a cfDNA methylation-based inflammation score (inflammation-DNAm score) based on 54 CpGs previously associated with circulating C-reactive protein concentrations. Associations of DNAm scores with HCC were assessed using multivariable logistic regression models. Receiver operating characteristic analysis was conducted to assess the performance of discriminating HCC between the inflammation-DNAm score and alpha-fetoprotein (AFP), one of the current screening biomarkers. RESULTS: A higher inflammation-DNAm score was associated with a 29% increase in the odds of HCC (OR = 1.29, 95% CI = 1.01-1.65). The association remained consistent in the models adjusted for cellular origin proportions. The DNAm score exhibited superior performance in discriminating HCC from controls (AUC = 0.94, 95% CI = 0.90-0.98), compared to AFP (AUC = 0.68, 95% CI = 0.51-0.85). CONCLUSIONS: Our findings suggest that cfDNA methylation-based biomarkers may aid in the detection of HCC in people living with HIV, a population at high-risk of developing HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsDNA MethylationHIV InfectionsCell-Free Nucleic AcidsInflammationHumansMaleFemaleMiddle AgedAdultBiomarkers, Tumoralpha-FetoproteinsC-Reactive ProteinROC Curve

Stichwörter der Autor:innen

C-reactive proteinCell-free DNA methylationHepatocellular carcinomaMethylation risk scoreMethylation-based inflammation measures

Substanzen

Cell-Free Nucleic AcidsBiomarkers, Tumoralpha-FetoproteinsC-Reactive Protein

Autor:innen und Institutionen

  • Sungkyunkwan University School of Medicine, 2066 Seobu-ro, Jangan-gu, Suwon-si, Gyeonggi-do, 16419, South Korea. kyeezu.kim@skku.edu.
  • Northwestern University Feinberg School of Medicine, Chicago, IL, USA. kyeezu.kim@skku.edu.
  • Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Robert J. Harvey, MD Institute for Global Health, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • University of Jos, Jos, Nigeria.
  • University of Lagos, Lagos, Nigeria.

Förderung

  • NCI NIH HHS
  • National Research Foundation of Korea
  • Division of Cancer Prevention, National Cancer Institute

Zitieren

APA

Kim, K., Zheng, Y., Joyce, B. T., Nannini, D. R., Wang, J., Qu, Y., Hawkins, C. A., Okeke, E., Lesi, O. A., Roberts, L. R., Gursel, D. B., Abdulkareem, F. B., Akanmu, A. S., Duguru, M. J., Davwar, P., Nyam, D. P., Adisa, R. A., Imade, G., Wei, J. J., …, & Hou, L. (2025). Cell-free DNA methylation-based inflammation score as a marker for hepatocellular carcinoma among people living with HIV. Hepatology International, 19(3), 596-606. https://doi.org/10.1007/s12072-024-10768-1

Vancouver

Kim K, Zheng Y, Joyce BT, Nannini DR, Wang J, Qu Y, et al. Cell-free DNA methylation-based inflammation score as a marker for hepatocellular carcinoma among people living with HIV. Hepatology International. 2025;19(3):596-606. doi:10.1007/s12072-024-10768-1

BibTeX
@article{Kim2025,
  author = {Kim, Kyeezu and Zheng, Yinan and Joyce, Brian T and Nannini, Drew R and Wang, Jun and Qu, Yishu and Hawkins, Claudia A and Okeke, Edith and Lesi, Olufunmilayo A and Roberts, Lewis R and Gursel, Demirkan B and Abdulkareem, Fatimah B and Akanmu, Alani S and Duguru, Mary J and Davwar, Pantong and Nyam, David Paul and Adisa, Rahmat A and Imade, Godwin and Wei, Jian-Jun and Kocherginsky, Masha and Kim, Kwang-Youn and Adeyemo, Wasiu L and Odeghe, Emuobor and Wehbe, Firas H and Achenbach, Chad and Sagay, Atiene and Ogunsola, Folasade and Murphy, Robert L and Hou, Lifang},
  title = {Cell-free DNA methylation-based inflammation score as a marker for hepatocellular carcinoma among people living with HIV},
  journal = {Hepatology International},
  year = {2025},
  volume = {19},
  number = {3},
  pages = {596--606},
  doi = {10.1007/s12072-024-10768-1}
}
Kostenlos starten →